Sign Up to like & get
recommendations!
1
Published in 2020 at "FEBS Open Bio"
DOI: 10.1002/2211-5463.12806
Abstract: Nearly half of human cancers harbor p53 mutations, and mutant p53 (mutp53) promotes carcinogenesis, metastasis, tumor recurrence and chemoresistance. mutp53 is observed in 30% of breast carcinomas, including triple‐negative breast cancer (TNBC), and thus mutp53…
read more here.
Keywords:
degradation;
bez235;
tnbc;
mutant p53 ... See more keywords
Photo from wikipedia
Sign Up to like & get
recommendations!
1
Published in 2018 at "Cancer Chemotherapy and Pharmacology"
DOI: 10.1007/s00280-018-3610-z
Abstract: PurposeTo determine the maximum tolerated dose (MTD) of BEZ235, an oral inhibitor of class I PI3K and mTOR complexes 1 and 2.MethodsWe performed a phase I/Ib, multicenter, open-label study of oral BEZ235 administered in a…
read more here.
Keywords:
pi3k mtor;
dose escalation;
bez235;
study ... See more keywords
Photo from wikipedia
Sign Up to like & get
recommendations!
1
Published in 2018 at "Cancer Chemotherapy and Pharmacology"
DOI: 10.1007/s00280-018-3725-2
Abstract: PurposeBEZ235 is a dual kinase inhibitor of phosphatidylinositol 3-kinase (PI3K) and mammalian target of rapamycin, which are key components of the PI3K pathway. This was an open-label, multicenter, dose-escalation, phase I study of single-agent BEZ235…
read more here.
Keywords:
solid tumors;
advanced solid;
bez235;
study ... See more keywords
Photo from wikipedia
Sign Up to like & get
recommendations!
0
Published in 2020 at "Journal of biomedical nanotechnology"
DOI: 10.1166/jbn.2020.2834
Abstract: AIM To assess AB-BEZ235-NP potential as a radio-sensitizer in hepatocellular carcinoma models. METHOD By comparing hepatocellular carcinoma cell with simple radiation or combined AB-BEZ235-NP therapy, the HCC apoptosis and self-repair level have significant differences in…
read more here.
Keywords:
hepatocellular carcinoma;
radiosensitivity;
dna;
bez235 ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2018 at "Oncotarget"
DOI: 10.18632/oncotarget.23711
Abstract: Osteosarcoma(OS) remains a major health concern in childhood and adolescence, although cisplatin is one of the gold standard chemotherapeutic drugs in the treatment of OS, chemoresistant to cisplatin is common. Phosphoinositide 3-kinase (PI3K)-Akt-mammalian target of…
read more here.
Keywords:
bez235;
nvp bez235;
osteosarcoma;
cisplatin sensitivity ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2019 at "Cancers"
DOI: 10.3390/cancers11081204
Abstract: Our previous study demonstrated that administration of NVP-BEZ235 (BEZ235), a dual PI3K/mTOR inhibitor, before radiotherapy (RT) enhanced the radiotherapeutic effect in colorectal cancer (CRC) cells both in vitro and in vivo. Here, we evaluated whether…
read more here.
Keywords:
treatment;
bez235;
maintenance bez235;
bez235 mbez235 ... See more keywords
Sign Up to like & get
recommendations!
2
Published in 2022 at "Cancers"
DOI: 10.3390/cancers14133160
Abstract: Simple Summary Head and neck cancers (HNSCCs), especially in the advanced stages, are predominantly treated by radiochemotherapy, including cisplatin. The cure rates are clearly higher for HPV-positive HNSCCs when compared to HPV-negative HNSCCs. For both…
read more here.
Keywords:
hpv negative;
cisplatin radiation;
bez235;
hpv positive ... See more keywords